为解决 ARMMs 临床应用的生产难题，研究人员评估两种策略，实现大规模生产，推进其体内治疗应用。 细胞 “快递员” 的升级之路：工程化 ARRDC1 介导微泡的创新研究 在生命的微观世界里，细胞之间时刻进行着繁忙的 “信息交流”，细胞外囊泡（Extracellular ...

Producing therapeutic ARMMs entails engineering producer cells to express the ARRDC1 gene and the payload of interest. The therapeutic cargo is directly loaded into ARMMs, which can be collected ...

ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can deliver broad range of larger, more varied cargoes - ...

MOUNTAIN VIEW, Calif., March 26, 2025 /PRNewswire/ -- Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles ...